Recovery & Repair

BPC-157 Injectable

Direct-to-tissue repair signaling.

PureBody MD

10mg vial

Subcutaneous BPC-157 delivers the peptide directly into systemic circulation, bypassing first-pass metabolism for maximum availability at musculoskeletal injury sites. Clinicians favor the injectable route for tendinopathy, ligament sprains, post-surgical recovery, and nerve regeneration, where consistent plasma levels drive angiogenesis and fibroblast migration into damaged tissue. Injections may be placed near the injury site for regional concentration.

Clinical indications

Highest bioavailability
Site-specific dosing
Accelerated tendon repair
Nerve regeneration support

Typical dosing protocol

250–500 mcg subcutaneous, 1–2x daily, 4–6 week cycles

Suggested reference only. Final dosing is set by the prescribing clinician in our independent third-party network.

Also in Recovery & Repair

BPC-157

The body's own repair signal, concentrated.

TB-500

Systemic recovery for hard-training athletes.

BPC-157 (Oral)

Needle-free gut and tissue repair.